In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial
Kruse T, Hansen JL, Dahl K, Schffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K
Genetic factors contribute to the risk of developing endometriosis
The UK's First GLP-1 Weight Loss Tablet: A New Chapter in Obesity Care Obesity is one of the most pressing public health challenges of our time, affecting millions of people worldwide and significantly increasing the risk of conditions such as type 2 diabetes, cardiovascular disease, hypertension and sleep apnoea
The recommendation is to take NSAIDs with whatever food you do eat, use the lowest effective dose, and consider switching to acetaminophen for pain management where possible
Ultimately, most patients taking these medications discontinue treatment because of side effects or financial concerns, which puts them at risk to regain the lost weight